You are here

Asymptomatic individuals: screening/assessment

Recommendations from the World Health Organization (WHO) and the International Atomic Energy Agency (IAEA) following the 2012 Bonn meeting highlighted the need for justification guidance for screening programmes and individual health surveillance. This guidance will be helpful to both the asymptomatic individual seeking imaging assessment and for policy makers who are planning screening programmes.

The use of CT in screening should be directed at those groups at high risk where there is supporting evidence. At present, there is no evidence to support general population health screening with CT.

Clinical/diagnostic problemGuideline
Breast screening: women <40 years old
(See also B05)
B01
Breast screening: women 40–49 years old (the precise age range will depend on the lower limit for invitation through national screening programmes – see comment)B02
Breast screening: women 50–70 years old (the precise age for invitation will depend on national screening programmes – see comment)B03
Breast screening: women >70 years old (the precise age will depend on national screening programmes – see comment)B04
Breast screening: women with increased lifetime risk of developing breast cancer, including those with family history and previous mediastinal radiotherapy (See also B01)B05
Lung cancer screening and individual health assessment for lung cancerCC27
Incidentally detected lung nodules: follow-upCC28
Asymptomatic patients 50–75 years old with a positive faecal occult blood test on screening for bowel cancerG27
Asymptomatic men with elevated PSAU20
Incidentally detected non-functioning adrenal massU17
Abdominal aortic aneurysm: screening of asymptomatic men over 65 yearsI06
Asymptomatic carotid bruitN18
Heart murmur in childrenP06
Spina bifida occulta in childrenP18